The role of the Xpert MTB/RIF assay among adolescents suspected of pulmonary tuberculosis in Rio de Janeiro, Brazil
Abstract INTRODUCTION The teste rápido molecular para tuberculose (TRM-TB) was introduced in 2014 in Brazil for tuberculosis screening. However, its role in adolescents in Brazil has not been studied. METHODS A descriptive study of adolescents with suspected tuberculosis using National Laboratory software. RESULTS Of 852 (15.4%) suspected cases, 131 were positive by TRM-TB and 2% were resistant to rifampicin. Among TRM-TB-positive cases, 105 (91.4%) were culture-positive. Sixty-four of 96 samples were sensitive to rifampicin by TRM-TB; 11 were resistant to other drugs by drug sensitivity test (DST). CONCLUSIONS Among suspected cases, 16% were diagnosed by TRM-TB, of which 17% were drug-resistant by DST.
Saved in:
Main Authors: | Sieiro,Thania Luiza de Andrade, Aurílio,Rafaela Baroni, Soares,Elizabeth Cristina C., Chiang,Silvia S., Sant´Anna,Clemax Couto |
---|---|
Format: | Digital revista |
Language: | English |
Published: |
Sociedade Brasileira de Medicina Tropical - SBMT
2018
|
Online Access: | http://old.scielo.br/scielo.php?script=sci_arttext&pid=S0037-86822018000200234 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
The use of Gene-Xpert MTB RIF in the diagnosis of extrapulmonary tuberculosis in childhood and adolescence
by: Aurilio,Rafaela Baroni, et al.
Published: (2020) -
Comparison of GeneXpert MTB/RIF assay and LED-FM microscopy for the diagnosis of extra pulmonary tuberculosis in Khyber Pakhtunkhwa, Pakistan
by: Khan,Anwar Sheed, et al.
Published: (2018) -
Ensayo Xpert MTB/RIF en el diagnóstico de tuberculosis
by: VALLEJO V,PATRICIO, et al.
Published: (2015) -
Cost-effectiveness of Xpert®MTB/RIF in the diagnosis of tuberculosis: pragmatic study
by: Silva,Suely Conceição Alves da, et al.
Published: (2021) -
The value of GeneXpert MTB/RIF in bronchoalveolar lavage fluid in the diagnosis of smear-negative pulmonary tuberculosis.
by: Zhou,Yue-Ying, et al.
Published: (2021)